Barrett's esophagus (BE) is the only known precursor to esophageal adenocarcinoma
(EAC). Methods of identifying BE patients at high risk for progression to high-grade …

Background & Aims In patients with Barrett's esophagus (BE), low-grade dysplasia (LGD) is
a risk factor for esophageal adenocarcinoma (EAC), progressing at variable rates. Patients …

Background & Aims A system is needed to determine the risk of patients with Barrett's
esophagus for progression to high-grade dysplasia (HGD) and esophageal …

Barrett's esophagus (BE) is the strongest risk factor for esophageal adenocarcinoma (EAC),
a malignancy with persistently poor long-term outcomes. EAC is thought to develop through …

OBJECTIVES: In patients with high-grade dysplasia (HGD) in Barrett's esophagus (BE), it is
incompletely known which factors are associated with developing esophageal …

Background The natural history of low-grade dysplasia (LGD) in patients with Barrett's
esophagus (BE) is unclear. Objective We performed a systematic review and meta-analysis …

OBJECTIVES: Patients with Barrett's esophagus (BE) have an increased risk of developing
esophageal adenocarcinoma (EAC). As the absolute risk remains low, there is a need for …

BACKGROUND & AIMS: The risks of dysplasia and esophageal adenocarcinoma (EAC) are
not clear for patients with nondysplastic Barrett's esophagus (NDBE); the rate of progression …

BACKGROUND & AIMS: Data vary on the progression of low-grade dysplasia (LGD) in
patients with Barrett's esophagus (BE); in patients with LGD, we investigated the incidence …

Background and Aims Risk of progression in Barrett's esophagus (BE) with low-grade
dysplasia (LGD) and high-grade dysplasia (HGD) has been established. However, the …